chr4-112963140-G-C

Variant summary

Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_StrongBA1

The ENST00000506722.5(ANK2):​c.21+58626G>C variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.086 in 152,096 control chromosomes in the GnomAD database, including 902 homozygotes. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.

Frequency

Genomes: 𝑓 0.086 ( 902 hom., cov: 32)

Consequence

ANK2
ENST00000506722.5 intron

Scores

2

Clinical Significance

Not reported in ClinVar

Conservation

PhyloP100: -0.0360

Publications

1 publications found
Variant links:
Genes affected
ANK2 (HGNC:493): (ankyrin 2) This gene encodes a member of the ankyrin family of proteins that link the integral membrane proteins to the underlying spectrin-actin cytoskeleton. Ankyrins play key roles in activities such as cell motility, activation, proliferation, contact and the maintenance of specialized membrane domains. Most ankyrins are typically composed of three structural domains: an amino-terminal domain containing multiple ankyrin repeats; a central region with a highly conserved spectrin binding domain; and a carboxy-terminal regulatory domain which is the least conserved and subject to variation. The protein encoded by this gene is required for targeting and stability of Na/Ca exchanger 1 in cardiomyocytes. Mutations in this gene cause long QT syndrome 4 and cardiac arrhythmia syndrome. Multiple transcript variants encoding different isoforms have been described. [provided by RefSeq, Dec 2011]
ANK2 Gene-Disease associations (from GenCC):
  • complex neurodevelopmental disorder
    Inheritance: AD Classification: DEFINITIVE, MODERATE Submitted by: Ambry Genetics, ClinGen
  • Brugada syndrome
    Inheritance: AD Classification: LIMITED, NO_KNOWN Submitted by: Genomics England PanelApp, ClinGen
  • catecholaminergic polymorphic ventricular tachycardia
    Inheritance: AD Classification: LIMITED, NO_KNOWN Submitted by: ClinGen, Genomics England PanelApp
  • heart conduction disease
    Inheritance: AD Classification: LIMITED Submitted by: Genomics England PanelApp
  • neurodevelopmental disorder
    Inheritance: AD Classification: LIMITED Submitted by: G2P
  • cardiac arrhythmia, ankyrin-B-related
    Inheritance: Unknown, AD Classification: LIMITED Submitted by: Labcorp Genetics (formerly Invitae), Ambry Genetics
  • long QT syndrome
    Inheritance: AD Classification: NO_KNOWN Submitted by: ClinGen

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -12 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.88).
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.191 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
ANK2NM_001386142.1 linkc.21+58626G>C intron_variant Intron 2 of 44 NP_001373071.1
ANK2NM_001386143.1 linkc.21+58626G>C intron_variant Intron 2 of 47 NP_001373072.1
ANK2NM_001386186.2 linkc.73-211276G>C intron_variant Intron 1 of 46 NP_001373115.1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
ANK2ENST00000506722.5 linkc.21+58626G>C intron_variant Intron 2 of 46 1 ENSP00000421067.1 Q01484-5
ANK2ENST00000672209.1 linkc.21+58626G>C intron_variant Intron 2 of 47 ENSP00000499982.1 A0A5F9ZH30
ANK2ENST00000673298.1 linkc.21+58626G>C intron_variant Intron 2 of 46 ENSP00000500245.1 A0A5F9ZHE4

Frequencies

GnomAD3 genomes
AF:
0.0859
AC:
13054
AN:
151978
Hom.:
896
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.194
Gnomad AMI
AF:
0.0779
Gnomad AMR
AF:
0.0742
Gnomad ASJ
AF:
0.0505
Gnomad EAS
AF:
0.0306
Gnomad SAS
AF:
0.0126
Gnomad FIN
AF:
0.0257
Gnomad MID
AF:
0.0665
Gnomad NFE
AF:
0.0434
Gnomad OTH
AF:
0.0862
We have no GnomAD4 exomes data on this position. Probably position not covered by the project.
GnomAD4 genome
AF:
0.0860
AC:
13086
AN:
152096
Hom.:
902
Cov.:
32
AF XY:
0.0841
AC XY:
6255
AN XY:
74344
show subpopulations
African (AFR)
AF:
0.195
AC:
8070
AN:
41490
American (AMR)
AF:
0.0741
AC:
1132
AN:
15282
Ashkenazi Jewish (ASJ)
AF:
0.0505
AC:
175
AN:
3464
East Asian (EAS)
AF:
0.0307
AC:
159
AN:
5182
South Asian (SAS)
AF:
0.0122
AC:
59
AN:
4820
European-Finnish (FIN)
AF:
0.0257
AC:
272
AN:
10600
Middle Eastern (MID)
AF:
0.0646
AC:
19
AN:
294
European-Non Finnish (NFE)
AF:
0.0434
AC:
2948
AN:
67942
Other (OTH)
AF:
0.0858
AC:
181
AN:
2110
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.503
Heterozygous variant carriers
0
598
1196
1794
2392
2990
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
130
260
390
520
650
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.0737
Hom.:
86
Bravo
AF:
0.0966
Asia WGS
AF:
0.0320
AC:
112
AN:
3474

ClinVar

Not reported in ClinVar

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.88
CADD
Benign
1.6
DANN
Benign
0.41
PhyloP100
-0.036
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs17045162; hg19: chr4-113884296; API